Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 43Myelodysplastic Syndromes 41Leukemia 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, Non-Hodgkin 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Leukemia, Lymphocytic, Chronic, B-Cell 23Lymphoma 22Hodgkin Disease 22Hematologic Neoplasms 22Multiple Myeloma 18Graft vs Host Disease 14Myeloproliferative Disorders 13Primary Myelofibrosis 12Leukemia, Myelomonocytic, Juvenile 11Lymphoma, Mantle-Cell 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 9Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myelomonocytic, Chronic 7Lymphoma, Large-Cell, Immunoblastic 6Leukemia, Myeloid, Accelerated Phase 6Congenital Abnormalities 6Burkitt Lymphoma 6Waldenstrom Macroglobulinemia 5Neuroblastoma 5Neoplasms 5Lymphoma, T-Cell, Cutaneous 5Leukemia, Myeloid, Chronic-Phase 5Blast Crisis 5

Interventions

rozanolixizumab 11efgartigimod alfa 10zilucoplan 8Prednisone 8Cyclophosphamide 8ravulizumab 7Rituximab 7Pyridostigmine Bromide 7telitacicept 6fludarabine 6Tacrolimus 6Mycophenolic Acid 6eculizumab 5Immunoglobulins, Intravenous 5Hizentra 4Azathioprine 4Steroids 3HBM9161 3Data Collection 3Amifampridine 3thymoglobulin 2inebilizumab 2Thymectomy 2Prednisolone 2Methylprednisolone 2Methotrexate 2Exercise 2Diagnostic Self Evaluation 2Blood Specimen Collection 2tofacitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Myasthenia Gravis × thymoglobulin × Clear all
NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
53 enrolled
CNS

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

NCT00424489 2018-08-31

Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis

Northwestern University

Phase 1 Terminated
9 enrolled 8 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡